


2024 Purpose Awards – Jaysson Eicholtz









Ajinomoto Co., Inc. to acquire Forge Biologics for $620 million









Ajinomoto jumps into gene therapy CDMO space through $620m Forge buy









Why the market leader in umami acquired a Central Ohio gene therapy startup









Ajinomoto Targets Gene Therapy Space, Bolsters Biopharma Services with $620M Forge Acquisition









CDMO Ajinomoto forges ahead with Forge Biologics in $620M acquisition









Forge Biologics of Grove City bought by Japanese firm for $620 million








